Orthopedic Imaging Equipment Market (By Modality: X-ray, MRI, CT; By Indication: Trauma Cases, Bone Disorders; By End Use: Hospitals, Diagnostic Imaging Centers) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

Orthopedic Imaging Equipment Market Size and Growth

The global orthopedic imaging equipment market size was estimated at around USD 4.95 billion in 2023 and it is projected to hit around USD 8.16 billion by 2033, growing at a CAGR of 5.13% from 2024 to 2033. The orthopedic imaging equipment market is a vital component of the healthcare industry, providing crucial diagnostic tools for the assessment and treatment of musculoskeletal conditions.

Orthopedic Imaging Equipment Market Size 2024 to 2033

Key Pointers

  • North America led the global market with the largest market share of 35% in 2023.
  • Asia Pacific is expected to expand at the highest CAGR from 2024 to 2033.
  • By Modality, the X-ray category held the largest revenue share of 33% in 2023.
  • By Modality, the CT segment is estimated to expand the fastest CAGR between 2024 to 2033.
  • By Indication, the trauma cases segment captured the maximum market share of 21% in 2023.
  • By End-use, the hospital segment generated the maximum market share of 47% in 2023.
  • By End-use, the diagnostic imaging centers segment is anticipated to grow at the noteworthy CAGR of 2024 to 2033.

Orthopedic Imaging Equipment Market Growth Factors

The growth of the orthopedic imaging equipment market is propelled by an increasing prevalence of orthopedic disorders, coupled with the aging population worldwide, has led to a growing demand for advanced diagnostic tools to assess musculoskeletal conditions. Additionally, technological advancements in imaging modalities, such as MRI, CT scanners, and ultrasound systems, have significantly enhanced diagnostic accuracy and efficiency, further driving market growth. Moreover, the rising adoption of minimally invasive procedures in orthopedic surgery necessitates the use of sophisticated imaging equipment for precise pre-operative planning and intraoperative guidance. These factors collectively contribute to the robust expansion of the orthopedic imaging equipment market, with sustained innovation and evolving healthcare needs poised to fuel future growth.

U.S. Orthopedic Imaging Equipment Market Size 2024 to 2033

The U.S. orthopedic imaging equipment market size was valued at USD 1.21 billion in 2023 and it is predicted to surpass around USD 1.99 billion by 2033 with a CAGR of 5.11% from 2024 to 2033.

U.S. Orthopedic Imaging Equipment Market Size 2024 to 2033

In 2023, the orthopedic imaging equipment market in North America clinched the leading share at 35%. Anticipated technological advancements and a mounting incidence of chronic conditions are poised to propel market expansion throughout the forecast period. Moreover, the widespread adoption of sophisticated imaging modalities for orthopedic applications among end-users is projected to fuel market growth. For instance, in September 2023, UC Davis Health unveiled a specialized clinic focused on musculoskeletal ultrasound, targeting patients grappling with rheumatological conditions.

Orthopedic Imaging Equipment Market Share, By Region, 2023 (%) 

Meanwhile, the orthopedic imaging equipment market in Asia Pacific is forecasted to witness the swiftest Compound Annual Growth Rate (CAGR) from 2024 to 2033. This surge is attributed to the burgeoning aging population, which is inherently more susceptible to geriatric orthopedic injuries, coupled with a burgeoning demand for state-of-the-art imaging devices.

Orthopedic Imaging Equipment Market Trends:  

  • Advancements in Technology: Continuous innovation in imaging technology, such as digital radiography and 3D/4D imaging, is driving improvements in diagnostic accuracy and efficiency.
  • Portable and Point-of-Care Devices: There's a notable trend towards the adoption of portable and point-of-care imaging devices, enabling on-the-go diagnostics and enhancing accessibility in emergency settings.
  • Value-Based Healthcare: Healthcare facilities are increasingly prioritizing value-based care delivery, leading to the adoption of cost-effective imaging solutions that offer improved patient outcomes and efficient resource utilization.
  • Integration of AI and Machine Learning: There's a growing integration of artificial intelligence (AI) and machine learning algorithms in orthopedic imaging, facilitating automated image analysis and interpretation, thereby streamlining workflow and enhancing diagnostic precision.
  • Focus on Personalized Medicine: With a shift towards personalized medicine, there's an increasing emphasis on tailoring treatment approaches to individual patient needs. Advanced imaging modalities play a crucial role in enabling personalized diagnosis and treatment planning for orthopedic conditions.

Orthopedic Imaging Equipment Market Restraints:

  • High Initial Capital Investment: The acquisition cost of advanced orthopedic imaging equipment, coupled with ongoing maintenance expenses, poses a significant financial barrier for healthcare providers, particularly in resource-constrained settings.
  • Regulatory Compliance Challenges: Stringent regulatory requirements and certification processes for orthopedic imaging equipment impose compliance burdens on manufacturers, leading to delays in product launches and increased operational costs.
  • Limited Access in Underserved Areas: Rural and underserved regions often face challenges in accessing specialized orthopedic imaging services due to inadequate healthcare infrastructure and limited availability of trained personnel, exacerbating healthcare disparities and hindering market growth.
  • Technological Obsolescence: Rapid advancements in imaging technology render existing equipment obsolete over time, necessitating frequent upgrades or replacements to maintain competitiveness, which can strain healthcare budgets and disrupt workflow continuity.
  • Safety Concerns: Despite the benefits of ionizing radiation-based imaging modalities such as X-ray and CT scans, there are inherent radiation exposure risks associated with prolonged or frequent use, raising concerns among healthcare professionals and patients regarding potential adverse health effects.

Modality Insights

The X-ray category dominated the market with a significant share of over 33% in 2023. X-rays serve as invaluable diagnostic tools primarily employed to detect diseases and anomalies within bone structures. These encompass degenerative ailments, fractures, dislocations, infections, and tumors. Moreover, they offer a cost-effective and easily accessible imaging solution, readily available in hospitals and clinics. However, X-rays may not always furnish a comprehensive diagnosis for soft tissue injuries such as muscle, tendon, or ligament damage, as their efficacy lies in visualizing bone and dense tissues.

On the other hand, the CT segment is projected to exhibit the highest Compound Annual Growth Rate (CAGR) from 2024 to 2033. CT scans are highly efficient in orthopedic imaging due to their capability to deliver detailed images of bone structures. This proves beneficial in diagnosing intricate fractures or assessing the extent of damage in traumatic cases. Additionally, CT scans can be utilized for image guidance during bone biopsy or joint injection procedures.

Indication Insights

In 2023, the trauma cases segment commanded the largest market share, surpassing 21%, driven by the surge in sports injuries and accidents. For example, data from the WHO released in December 2023 revealed that approximately 1.19 million individuals perish annually due to road traffic accidents. Consequently, prompt and accurate diagnosis is imperative for effective treatment, particularly in sports medicine and emergency care contexts. Orthopedic imaging assumes a pivotal role in evaluating injury severity and facilitating crucial interventions. Conversely, the arthritis segment is poised to exhibit the swiftest Compound Annual Growth Rate (CAGR) from 2024 to 2030.

This ascent can be attributed to the escalating prevalence of arthritis and the burgeoning geriatric populace. While arthritis can afflict individuals across all age groups, its incidence notably escalates beyond 45 years of age. The condition can significantly compromise physical well-being owing to the pain and functional constraints it entails. For instance, statistics from the Centers for Disease Control and Prevention indicate that approximately 1 in 5 adults in the US (21.2%), totaling around 53.2 million individuals, received an arthritis diagnosis during the period spanning 2019 to 2021. The accessibility, affordability, and non-invasive nature of orthopedic imaging products constitute key drivers underpinning their demand within this segment.

End-use Insights

In 2023, the hospital segment emerged as the dominant force in the orthopedic imaging devices market, commanding a share exceeding 47%. Hospitals stand as the primary choice for patients seeking orthopedic care, be it for chronic ailments or sudden injuries. This preference stems from hospitals' comprehensive capabilities in managing diverse orthopedic cases, facilitated by a plethora of medical services housed under one roof, encompassing emergency departments, surgical suites, and inpatient facilities. Moreover, hospitals boast access to cutting-edge orthopedic imaging equipment, including nuclear imaging, MRI, CT, and X-ray machines, pivotal for both diagnosis and treatment monitoring processes.

Conversely, the diagnostic imaging centers segment is slated to witness substantial growth at a notable Compound Annual Growth Rate (CAGR) from 2024 to 2033. These centers specialize in offering a broad spectrum of imaging modalities, tailored specifically for orthopedic evaluations. Patients gravitate towards radiology centers due to their heightened efficiency, specialized expertise, and shortened appointment waiting periods. This proves particularly advantageous for individuals in pursuit of routine orthopedic assessments or non-emergency diagnostic procedures.

Orthopedic Imaging Equipment Market Key Companies

  • GE Healthcare
  • Philips Healthcare
  • Siemens Healthineers
  • Canon Medical Systems Corporation
  • Fujifilm Healthcare Solutions
  • Esaote
  • Carestream Health
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • United Imaging Healthcare Co.
  • Shimadzu Corporation
  • Hologic, Inc.

Recent Developments

  • In February 2023, GE Healthcare announced that it reached an agreement to acquire a privately held Artificial Intelligence (AI) healthcare provider, Caption Health, Inc. Caption Health develops clinical applications to help with early disease diagnosis and uses AI to help with ultrasound scans.
  • In   November 2022, Canon, Inc. decided to establish an entirely new subsidiary, which would be called Canon Healthcare USA, INC. Canon boosted the development of the medical business by expanding its position in the American medical market

Orthopedic Imaging Equipment Market Segmentation:

By Modality

  • X-ray
  • CT
  • MRI
  • Ultrasound
  • Nuclear Imaging

By Indication

  • Trauma Cases
  • Sport Injuries
  • Spinal Injuries
  • Arthritis
  • Bone Disorders
  • Musculoskeletal Cancer
  • Muscle Atrophy
  • Others

By End-use

  • Hospitals
  • Diagnostic Imaging Centers
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

The global orthopedic imaging equipment market size was reached at USD 4.95 billion in 2023 and it is projected to hit around USD 8.16 billion by 2033.

The global orthopedic imaging equipment market is growing at a compound annual growth rate (CAGR) of 5.13% from 2024 to 2033.

The North America region has accounted for the largest orthopedic imaging equipment market share in 2023.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Modality Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Orthopedic Imaging Equipment Market 

5.1. COVID-19 Landscape: Orthopedic Imaging Equipment Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Orthopedic Imaging Equipment Market, By Modality

8.1. Orthopedic Imaging Equipment Market, by Modality, 2024-2033

8.1.1 X-ray

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. CT

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. MRI

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Ultrasound

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.5. Nuclear Imaging

8.1.5.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Orthopedic Imaging Equipment Market, By Indication

9.1. Orthopedic Imaging Equipment Market, by Indication, 2024-2033

9.1.1. Trauma Cases

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Sport Injuries

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Spinal Injuries

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Arthritis

9.1.4.1. Market Revenue and Forecast (2021-2033)

9.1.5. Bone Disorders

9.1.5.1. Market Revenue and Forecast (2021-2033)

9.1.6. Musculoskeletal Cancer

9.1.6.1. Market Revenue and Forecast (2021-2033)

9.1.7. Muscle Atrophy

9.1.7.1. Market Revenue and Forecast (2021-2033)

9.1.8. Others

9.1.8.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Orthopedic Imaging Equipment Market, By End-use 

10.1. Orthopedic Imaging Equipment Market, by End-use, 2024-2033

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Diagnostic Imaging Centers

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Others

10.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Orthopedic Imaging Equipment Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Modality (2021-2033)

11.1.2. Market Revenue and Forecast, by Indication (2021-2033)

11.1.3. Market Revenue and Forecast, by End-use (2021-2033)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Modality (2021-2033)

11.1.4.2. Market Revenue and Forecast, by Indication (2021-2033)

11.1.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Modality (2021-2033)

11.1.5.2. Market Revenue and Forecast, by Indication (2021-2033)

11.1.5.3. Market Revenue and Forecast, by End-use (2021-2033)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Modality (2021-2033)

11.2.2. Market Revenue and Forecast, by Indication (2021-2033)

11.2.3. Market Revenue and Forecast, by End-use (2021-2033)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Modality (2021-2033)

11.2.4.2. Market Revenue and Forecast, by Indication (2021-2033)

11.2.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Modality (2021-2033)

11.2.5.2. Market Revenue and Forecast, by Indication (2021-2033)

11.2.5.3. Market Revenue and Forecast, by End-use (2021-2033)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Modality (2021-2033)

11.2.6.2. Market Revenue and Forecast, by Indication (2021-2033)

11.2.6.3. Market Revenue and Forecast, by End-use (2021-2033)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Modality (2021-2033)

11.2.7.2. Market Revenue and Forecast, by Indication (2021-2033)

11.2.7.3. Market Revenue and Forecast, by End-use (2021-2033)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Modality (2021-2033)

11.3.2. Market Revenue and Forecast, by Indication (2021-2033)

11.3.3. Market Revenue and Forecast, by End-use (2021-2033)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Modality (2021-2033)

11.3.4.2. Market Revenue and Forecast, by Indication (2021-2033)

11.3.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Modality (2021-2033)

11.3.5.2. Market Revenue and Forecast, by Indication (2021-2033)

11.3.5.3. Market Revenue and Forecast, by End-use (2021-2033)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Modality (2021-2033)

11.3.6.2. Market Revenue and Forecast, by Indication (2021-2033)

11.3.6.3. Market Revenue and Forecast, by End-use (2021-2033)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Modality (2021-2033)

11.3.7.2. Market Revenue and Forecast, by Indication (2021-2033)

11.3.7.3. Market Revenue and Forecast, by End-use (2021-2033)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Modality (2021-2033)

11.4.2. Market Revenue and Forecast, by Indication (2021-2033)

11.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Modality (2021-2033)

11.4.4.2. Market Revenue and Forecast, by Indication (2021-2033)

11.4.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Modality (2021-2033)

11.4.5.2. Market Revenue and Forecast, by Indication (2021-2033)

11.4.5.3. Market Revenue and Forecast, by End-use (2021-2033)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Modality (2021-2033)

11.4.6.2. Market Revenue and Forecast, by Indication (2021-2033)

11.4.6.3. Market Revenue and Forecast, by End-use (2021-2033)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Modality (2021-2033)

11.4.7.2. Market Revenue and Forecast, by Indication (2021-2033)

11.4.7.3. Market Revenue and Forecast, by End-use (2021-2033)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Modality (2021-2033)

11.5.2. Market Revenue and Forecast, by Indication (2021-2033)

11.5.3. Market Revenue and Forecast, by End-use (2021-2033)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Modality (2021-2033)

11.5.4.2. Market Revenue and Forecast, by Indication (2021-2033)

11.5.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Modality (2021-2033)

11.5.5.2. Market Revenue and Forecast, by Indication (2021-2033)

11.5.5.3. Market Revenue and Forecast, by End-use (2021-2033)

Chapter 12. Company Profiles

12.1. GE Healthcare.

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Philips Healthcare.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Siemens Healthineers.

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Canon Medical Systems Corporation.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Fujifilm Healthcare Solutions.

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Esaote

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Carestream Health.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. United Imaging Healthcare Co.

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Shimadzu Corporation

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers